| Product NDC: | 0095-7075 |
| Proprietary Name: | Orbivan CF |
| Non Proprietary Name: | acetaminophen and butalbital |
| Active Ingredient(s): | 300; 50 mg/1; mg/1 & nbsp; acetaminophen and butalbital |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0095-7075 |
| Labeler Name: | ECR Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090956 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120308 |
| Package NDC: | 0095-7075-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0095-7075-01) |
| NDC Code | 0095-7075-01 |
| Proprietary Name | Orbivan CF |
| Package Description | 100 TABLET in 1 BOTTLE (0095-7075-01) |
| Product NDC | 0095-7075 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acetaminophen and butalbital |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120308 |
| Marketing Category Name | ANDA |
| Labeler Name | ECR Pharmaceuticals |
| Substance Name | ACETAMINOPHEN; BUTALBITAL |
| Strength Number | 300; 50 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |